FindTrial
Sign In

Immunity status of staff of AIIA against Covid-19

To study the prevalence of serum IgG antibodies against SARS Cov-2 in scholars and employees of AIIA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032743
Enrollment
300
Registered
2021-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

All India institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Scholars and employees of AIIA Willing to participate in study

Exclusion criteria

Exclusion criteria: Not willing to participate in study

Design outcomes

Primary

MeasureTime frame
To find prevalence of IgG antibodies against SARS Cov-2 infectionTimepoint: 1 year—

Secondary

MeasureTime frame
To study retrospectively the data for vyadhiksamatwaTimepoint: 6months—

Countries

India

Contacts

Public ContactDr Shalini Rai

All India institute of Ayurveda

vd.raishalini@gmail.com9389423843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026